FindTrial
Sign In

Multi-center Real-world Study for Comprehensive Management and Control of Diabetes Mellitus (Meishan RWE)

Multi-center Real-world Study for Comprehensive Management and Control of Diabetes Mellitus (Meishan RWE)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030394
Enrollment
Unknown
Registered
2020-03-01
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Innovation management group:Diabetes patients will be provided with innovative tools such as CDSS, digital diabetes education, and TRIO 2.0
General management group:Routine practice

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diabetic patients aged 18 years and above; 2. Patients will sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients who refuse or are unable to participate in the study.

Design outcomes

Primary

MeasureTime frame
The incidence of diabetic microvascular complications;—

Secondary

MeasureTime frame
Changes of HbA1c and blood glucose compliance rate after 6 months of application of CDSS alone;Incidence, prevalence, and progression of microvascular complications;Changes and control rates (HbA1c<7%) of HbA1c;Changes in blood lipids and blood pressure;The incidence of macrovascular complications;All-cause mortality and cardioascular mortality;Cost-effective rations of CDSS and Meishan pattern;—

Countries

China

Contacts

Public ContactDalong Zhu

The Affiliated Drum Tower Hospital of Nanjing University Medical School

meishanrwe@aliyun.com+86 21-64879163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026